Hydrogen Sulfide Mediating both Excitatory and Inhibitory Effects in a Rat Model of Meningeal Nociception and Headache Generation.

BACKGROUND/PURPOSE: Hydrogen sulfide (HS) is a neuromodulator acting through nitroxyl (HNO) when it reacts with nitric oxide (NO). HNO activates transient receptor potential channels of the ankyrin type 1 (TRPA1) causing release of calcitonin gene-related peptide from primary afferents. Activation of meningeal nociceptors projecting to the human spinal trigeminal nucleus (STN) may lead to headaches. In a rat model of meningeal nociception, the activity of spinal trigeminal neurons was used as read-out for the interaction between HS and NO.

METHODS

In anesthetized rats extracellular recordings from single neurons in the STN were made. Sodium sulfide (NaS) producing HS in the tissue and the NO donor diethylamine-NONOate (DEA-NONOate) were infused intravenously. HS was also locally applied onto the exposed cranial dura mater or the medulla. Endogenous production of HS was inhibited by oxamic acid, and NO production was inhibited by nitro-l-arginine methyl ester hydrochloride (l-NAME) to manipulate endogenous HNO formation.

KEY RESULTS

Systemic administration of NaS was followed either by increased ongoing activity (in 73%) or decreased activity (in 27% of units). Topical application of NaS onto the cranial dura mater caused a short-lasting activation followed by a long-lasting decrease in activity in the majority of units (70%). Systemic administration of DEA-NONOate increased neuronal activity, subsequent infusion of NaS added to this effect, whereas DEA-NONOate did not augment the activity after NaS. The stimulating effect of DEA-NONOate was inhibited by oxamic acid in 75% of units, and l-NAME following NaS administration returned the activity to baseline.

CONCLUSION

Individual spinal trigeminal neurons may be activated or (less frequently) inhibited by the TRPA1 agonist HNO, presumably formed by HS and NO in the STN, whereby endogenous HS production seems to be rate-limiting. Activation of meningeal afferents by HNO may induce decreased spinal trigeminal activity, consistent with the elevation of the electrical threshold caused by TRPA1 activation in afferent fibers. Thus, the effects of HS-NO-TRPA1 signaling depend on the site of action and the type of central neurons. The role of HS-NO-TRPA1 in headache generation seems to be ambiguous.